Need professional-grade analysis? Visit stockanalysis.com
$9.12B
61.96
1,021
N/A
Price Chart
Risk-Adjusted Performance
Sino BiologicalInc. (301047) Price Performance
Sino BiologicalInc. (301047) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY75.25, up 0.03% from the previous close.
Over the past year, 301047 has traded between a low of CNY56.11 and a high of CNY82.02. The stock has gained 30.7% over this period. It is currently 8.3% below its 52-week high.
Sino BiologicalInc. has a market capitalization of $9.12B, with a price-to-earnings ratio of 61.96.
About Sino BiologicalInc.
Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine development, and multispecific antibody development solutions, as well as solutions for MSCs therapy and in vitro efficacy evaluation. It serves academic research institutions, biotech companies, and pharmaceutical companies. Sino Biological,Inc. was founded in 2016 and is headquartered in Beijing, China.
Compare Sino BiologicalInc.
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $660.17M
- EBITDA
- $131.77M
- Profit Margin
- 20.12%
- EPS (TTM)
- 1.21
- Book Value
- 43.38
Technical Indicators
- 52 Week High
- CN¥85.00
- 52 Week Low
- CN¥55.76
- 50 Day MA
- CN¥72.32
- 200 Day MA
- CN¥73.02
- Beta
- 0.91
Valuation
- Trailing P/E
- 61.96
- Forward P/E
- 57.14
- Price/Sales
- 13.81
- Price/Book
- 1.72
- Enterprise Value
- $5.98B